Table 1. Baseline Characteristics of 32 Patients a,b.
| Data | |
|---|---|
| Age, y | 25.9 ± 14.2 (16-76) |
| Gender | |
| Male | 21 (65.6) |
| Female | 11 (34.4) |
| First symptom | |
| Mass | 27 (84.4) |
| Pain | 5 (15.6) |
| Past chemotherapy | 7 (21.9) |
| Past surgery | 3 (9.4) |
| Tumor size, cm | 7.3 ± 2.9 |
| Tumor Number | |
| 1 | 22 (68.8) |
| 2 | 2 (6.3) |
| 3 | 2 (6.3) |
| 4 | 2 (6.3) |
| 5 | 1 (3.1) |
| 6 | 3 (9.4) |
| Number of involved segment | |
| 1 | 12 (37.5) |
| 2 | 12 (37.5) |
| 3 | 4 (12.5) |
| 4 | 3 (9.4) |
| 5 | 1 (3.1) |
| Tumor vascularity | |
| Hypo | 29 (90.6) |
| Hyper | 3 (9.4) |
| Tumor location | |
| Right | 21 (65.6) |
| Left | 7 (21.9) |
| Both | 4 (12.5) |
| AST | 47.00 ± 27.657 |
| ALT | 77.25 ± 32.960 |
| ALP | 458.64 ± 354.223 |
| BIL | 0.6471 ± 0.53579 |
| PT | 13.490 ± 1.4611 |
aAbbreviations: AST, aspartate aminotransferase; ALT, alanine aminoteransferase; ALP, alkaline phosphatase; BIL, bilirubin; PT, prothrombin time.
bData are presented as Mean ± SD or No. (%).